Want to see IN:RAINBOW full AI Analyst Report?
Top Page
Rainbow Childrens Medicare Limited
(RAINBOW)
Select Model
Select Model
Rating:72Outperform
Price Target:
₹1,505.00
▲(11.58% Upside)
Action:Upgraded
Date:05/25/26
The score is driven primarily by solid financial performance (steady growth, strong margins, and improving leverage) and supportive technical momentum (price above key moving averages with positive MACD). The main constraint is valuation, with a high P/E and minimal dividend yield, plus the risk signaled by uneven free-cash-flow conversion.
Positive Factors
Specialized Clinical Focus
Rainbow’s clear specialization in pediatric and women’s health (including maternity, neonatal and NICU/PICU care) creates durable demand and clinical complexity. That focus builds referral networks, repeat patient flows and differentiated service capability that support stable volumes and higher-acuity revenues over time.
Negative Factors
Volatile Free Cash Flow
Wide swings in free cash flow reflect uneven timing of reinvestment and capex, undermining predictability of cash available for debt service, dividends, or opportunistic investment. Persistent volatility can constrain strategic choices and increase reliance on external funding during down years.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized Clinical Focus
Rainbow’s clear specialization in pediatric and women’s health (including maternity, neonatal and NICU/PICU care) creates durable demand and clinical complexity. That focus builds referral networks, repeat patient flows and differentiated service capability that support stable volumes and higher-acuity revenues over time.
Read all positive factors
Rainbow Childrens Medicare Limited (RAINBOW) vs. iShares MSCI India ETF (INDA)
Market Cap
₹145.32B
Dividend Yield0.22%
Average Volume (3M)8.91K
Price to Earnings (P/E)54.0
Beta (1Y)0.60
Revenue Growth12.35%
EPS Growth14.31%
CountryIN
Employees3,940
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)20.27
Shares Outstanding101,566,640
10 Day Avg. Volume4,219
30 Day Avg. Volume8,914
Financial Highlights & Ratios
PEG Ratio2.96
Price to Book (P/B)7.17
Price to Sales (P/S)6.93
P/FCF Ratio86.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,689.50Price Target Upside25.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)32.5
Revenue Forecast (FY)₹19.95B
Rainbow Childrens Medicare Limited Business Overview & Revenue Model
Company Description
Rainbow Children's Medicare Limited is a leading Indian healthcare provider managing a network of multi-specialty hospitals dedicated to pediatric, obstetrics, and gynecology services. Its comprehensive child health offerings include general pedia...
How the Company Makes Money
RAINBOW primarily earns revenue by delivering hospital and clinical care services to patients. Key revenue streams include (1) inpatient and outpatient clinical services in pediatrics and in obstetrics & gynecology (e.g., consultations, procedures...
Rainbow Childrens Medicare Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
58
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.03B | 15.16B | 12.97B | 11.74B | 9.74B |
| Gross Profit | 6.73B | 10.82B | 9.31B | 8.44B | 6.44B |
| EBITDA | 5.86B | 4.37B | 3.90B | 3.65B | 2.73B |
| Net Income | 2.78B | 2.43B | 2.17B | 2.11B | 1.38B |
Balance Sheet | |||||
| Total Assets | 27.75B | 23.77B | 21.70B | 17.76B | 14.24B |
| Cash, Cash Equivalents and Short-Term Investments | 4.38B | 6.94B | 5.02B | 3.81B | 2.03B |
| Total Debt | 8.91B | 7.64B | 7.65B | 5.70B | 5.79B |
| Total Liabilities | 11.11B | 9.02B | 9.05B | 7.06B | 6.89B |
| Stockholders Equity | 16.48B | 14.68B | 12.59B | 10.60B | 6.03B |
Cash Flow | |||||
| Free Cash Flow | 1.37B | 2.50B | -321.75M | 1.86B | 1.62B |
| Operating Cash Flow | 3.54B | 3.96B | 3.21B | 3.27B | 2.24B |
| Investing Cash Flow | -2.70B | -2.68B | -2.26B | -4.65B | -1.75B |
| Financing Cash Flow | -697.53M | -1.18B | -1.02B | 1.43B | -440.62M |
Rainbow Childrens Medicare Limited Technical Analysis
Positive
1348.80
Price Trends
1364.12
Positive
1282.14
Positive
1301.40
Positive
Market Momentum
24.04
Positive
68.85
Neutral
61.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RAINBOW, the sentiment is Positive. The current price of 1348.8 is below the 20-day moving average (MA) of 1427.61, below the 50-day MA of 1364.12, and above the 200-day MA of 1301.40, indicating a bullish trend. The MACD of 24.04 indicates Positive momentum. The RSI at 68.85 is Neutral, neither overbought nor oversold. The STOCH value of 61.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:RAINBOW.
Rainbow Childrens Medicare Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹145.32B | 54.05 | ― | 0.22% | 12.35% | 14.31% | |
67 Neutral | ₹1.26T | 65.50 | ― | 0.27% | 15.76% | 34.29% | |
67 Neutral | ₹712.38B | 68.95 | ― | 0.11% | 17.28% | 34.55% | |
66 Neutral | ₹350.97B | 65.10 | ― | 0.04% | 19.44% | 15.55% | |
64 Neutral | ₹404.12B | 50.30 | ― | 0.24% | 41.43% | 2.10% | |
61 Neutral | ₹1.06T | 74.26 | ― | 0.14% | 19.14% | 34.01% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:RAINBOW
Rainbow Childrens Medicare Limited
1,479.65
-48.25
-3.16%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,842.95
1,672.12
23.32%
IN:FORTIS
Fortis Healthcare Ltd.
951.50
188.35
24.68%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,100.90
-116.34
-9.56%
IN:MEDANTA
Global Health Limited
1,347.05
41.92
3.21%
IN:NH
Narayana Hrudayalaya Ltd.
1,988.85
-12.19
-0.61%
Rainbow Childrens Medicare Limited Corporate Events
Rainbow Children’s Medicare Files SEBI Regulation 74(5) Compliance Certificate
Apr 7, 2026
Rainbow Children’s Medicare Limited has submitted to NSE and BSE a compliance certificate obtained from its registrar and share transfer agent, KFIN Technologies Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Reg...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.